David S. Leibowitz

Palo Alto Medical FoundationPalo Alto, California - 94301 (650-321-4121) Palo Alto Medical Foundation Research ...Palo Alto, California - 94301 |
- CLINICAL TRIALS 10
- CONDITIONS25
- INTERVENTIONS29
- SINCE2003

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
August 2003 - July 2005

Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
June 2010 - February 2013

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
January 2008 - May 2010

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
November 2008 - August 2011

Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
September 2007 - May 2012

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
May 2005 - March 2010

Research Tissue Bank
September 2007 - December 2011

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Adenocarcinoma
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Colorectal Neoplasms
Myelofibrosis
Myeloid Metaplasia
Polycythemia
Polycythemia Vera
Thrombocythemia, Hemorrhagic
Thrombocytosis
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Carcinoma in Situ
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Ductal, Breast
Carcinoma, Ductal
Placebo
Rituximab
Quality-Of-Life Assessment
Filgrastim
Celecoxib
Psychosocial Assessment And Care
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Cyclophosphamide
Prednisone
Radiation Therapy
Lenalidomide
Pemetrexed Disodium
Oxaliplatin
Fludarabine Phosphate
Doxorubicin Hydrochloride
Etoposide
Vincristine Sulfate
Temsirolimus
Trastuzumab
Sorafenib Tosylate
Cetuximab
Irinotecan Hydrochloride
Chemotherapy
Vinorelbine Ditartrate



